Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6244)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2013 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shi TY, Zhang LN, Chen H, Wang L, Shen M, Zhang X, Zhang FC. Risk factors for hepatic decompensation in patients with primary biliary cirrhosis. World J Gastroenterol 2013; 19(7): 1111-1118 [PMID: 23467321 DOI: 10.3748/wjg.v19.i7.1111] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i7/1111.htm |
| Number | Citing Articles |
| 1 |
Gennaro D’Amico, Giovanni Perricone. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?. Current Hepatology Reports 2019; 18(2): 144 doi: 10.1007/s11901-019-00473-1
|
| 2 |
Lin-Xiang Huang, Zi-Long Wang, Rui Jin, Hong-Song Chen, Bo Feng. Incomplete response to ursodeoxycholic acid in primary biliary cholangitis: criteria, epidemiology, and possible mechanisms. Expert Review of Gastroenterology & Hepatology 2022; 16(11-12): 1065 doi: 10.1080/17474124.2022.2153672
|
| 3 |
Yazmín Karel Melchor-Mendoza, Braulio Martínez-Benítez, Aline Mina-Hawat, Gustavo Rodríguez-Leal, Ximena Duque, Segundo Moran-Villota. Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis with Limited Liver Transplantation Availability. Annals of Hepatology 2017; 16(3): 430 doi: 10.5604/01.3001.0009.8598
|
| 4 |
David Uihwan Lee, Ashton Harmacinski, Sindhura Kolachana, Aneesh Bahadur, KeeSeok Lee, Ki Jung Lee, Alex Pu, Harrison Chou, Gregory Hongyuan Fan, Raza Malik. The role of donor sex on the post-liver transplant outcomes in patients with primary sclerosing cholangitis. European Journal of Gastroenterology & Hepatology 2024; 36(4): 452 doi: 10.1097/MEG.0000000000002712
|
| 5 |
Xiaoli Fan, Tingting Wang, Yi Shen, Xiaotan Xi, Li Yang. Underestimated Male Prevalence of Primary Biliary Cholangitis in China: Results of a 16-yr cohort study involving 769 patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-06807-7
|
| 6 |
Kristel K. Leung, Gideon M. Hirschfield. Autoantibodies in Primary Biliary Cholangitis. Clinics in Liver Disease 2022; 26(4): 613 doi: 10.1016/j.cld.2022.06.004
|
| 7 |
TianYan Shi, Ting Zhang, LiNa Zhang, YunJiao Yang, HaoZe Zhang, FengChun Zhang. The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis. Medicine 2015; 94(44): e1888 doi: 10.1097/MD.0000000000001888
|
| 8 |
Ashnila Janmohamed, Palak J. Trivedi. Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC). Best Practice & Research Clinical Gastroenterology 2018; : 71 doi: 10.1016/j.bpg.2018.06.002
|
| 9 |
Xiaoli Fan, Ruoting Men, Ping Ni, Changli Lu, Tengfei Si, Yun Ma, Li Yang. Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis. Clinical Rheumatology 2020; 39(3): 795 doi: 10.1007/s10067-019-04853-2
|
| 10 |
Hydar El Jamaly, Guy D Eslick, Martin Weltman. Primary biliary cholangitis in pregnancy: A systematic review with meta-analysis. Hepatobiliary & Pancreatic Diseases International 2022; 21(3): 218 doi: 10.1016/j.hbpd.2022.03.005
|
| 11 |
Lifeng Wang, Ying Sun, Zheng Zhang, Yiqiong Jia, Zhengsheng Zou, Jinbiao Ding, Yuanyuan Li, Xiangsheng Xu, Lei Jin, Tao Yang, Zhiwei Li, Yanling Sun, Ji‐yuan Zhang, Sa Lv, Liming Chen, Baosen Li, M. Eric Gershwin, Fu‐Sheng Wang. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology 2015; 61(2): 627 doi: 10.1002/hep.27306
|
| 12 |
Pan Zhao, Wei-wei Liu, Jin-feng Li, Chun-ya Wang, Hao Wang, Jun Xu, Rui-fang Wang, Hao-zhen Yang, Cheng Jin, Zhen-man Wei. Predictors of liver failure in primary biliary cirrhosis. Upsala Journal of Medical Sciences 2015; 120(1): 47 doi: 10.3109/03009734.2014.985763
|
| 13 |
Maren H Harms, Willem J Lammers, Douglas Thorburn, Christophe Corpechot, Pietro Invernizzi, Harry L A Janssen, Pier M Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, Cyriel Y Ponsioen, Marlyn J Mayo, George N Dalekos, Tony Bruns, Albert Parés, Andrew L Mason, Xavier Verhelst, Kris V Kowdley, Jorn C Goet, Gideon M Hirschfield, Bettina E Hansen, Henk R van Buuren. Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome. American Journal of Gastroenterology 2018; 113(2): 254 doi: 10.1038/ajg.2017.440
|
| 14 |
Paul J. Pockros, Michael Fuchs, Bradley Freilich, Eugene Schiff, Anita Kohli, Eric J. Lawitz, Paul A. Hellstern, Janet Owens‐Grillo, Courtney Van Biene, Reshma Shringarpure, Leigh MacConell, David Shapiro, David E. Cohen. CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients. Liver International 2019; 39(11): 2082 doi: 10.1111/liv.14209
|
| 15 |
Lukas Burghart, Emina Halilbasic, Philipp Schwabl, Benedikt Simbrunner, Albert Friedrich Stättermayer, Oleksandr Petrenko, Bernhard Scheiner, David Bauer, Matthias Pinter, Kaan Boztug, Mattias Mandorfer, Michael Trauner, Thomas Reiberger. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis. Journal of Gastroenterology 2022; 57(2): 99 doi: 10.1007/s00535-021-01839-3
|
| 16 |
Shu X. Li, Ting T. Lv, Chun P. Zhang, Tian Q. Wang, Dan Tian, Guang Y. Sun, Yan Wang, Xin Y. Zhao, Wei J. Duan, Sha Chen, Min Li, Hong Ma, Yuan Y. Kong, Hong You, Xiao J. Ou, Guang Y. Chen, Jian R. Su, Dong Zhang, Ji D. Jia. Alteration of liver‐infiltrated and peripheral blood double‐negative T‐cells in primary biliary cholangitis. Liver International 2019; 39(9): 1755 doi: 10.1111/liv.14136
|